EUVIMEDEUVIMED entdecken
Open Access

Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating Apoptosis

Mervenur Yavuz iD, Betül Şahin iD, Ahmet Tarık Baykal iD, Turan Demircan iD

Turkish Journal of Biology · 01.01.2023 · 47 (1) · 44-60

DOI: 10.55730/1300-0152.2640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Biology, online erschienen am 01.01.2023. Verfasst von Mervenur Yavuz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Muğla Sıtkı Koçman University, Muğla, Turkey. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast and ovarian cancers are women's most commonly diagnosed cancers. Seeking an efficient anticarcinogenic compound is still a top priority regarding the aggressiveness of these cancers and the limited benefit of current therapies. Hydroquinidine (HQ) is a natural alkaloid used in arrhythmia and Brugada syndrome. As an ion channel blocker, HQ exhibits its activity by altering ion gradient and membrane potential. Considering the growing evidence of ion channel blockers' antineoplastic potential, we were prompted to test HQ's effect on breast and ovarian cancers. MCF-7 and SKOV-3 cell lines were used to inspect how HQ acts on survival, clonogenicity, migration, tumorigenicity, proliferation, and apoptosis. The molecular basis for the remarkable antiproliferative and proapoptotic effect of HQ in these cells was dissected by proteomics. CDK1, PSMB5, PSMC2, MCM2, MCM7, YWHAH, YWHAQ, and YWHAB proteins in HQ-treated MCF-7 cells, and RRM2, PSMD2, PSME2, COX2, COX4l1, and CDK6 proteins in HQ-treated SKOV-3 cells were found as low-abundant, which was noteworthy. Based on the in-depth analysis, upon HQ treatment, several cell cycle-related processes were found as suppressed, whereas apoptosis and ferroptosis pathways were found to be activated. The observed proteome alteration in cancer cells may provide mechanistic explanations for the growth-limiting effects of HQ at the cellular level.

Schlagwörter

Stichwörter der Autor:innen

CancerMCF-7SKOV-3anticancer agenthydroquinidineproteomics

Autor:innen und Institutionen

  • Institute of Health Sciences, Muğla Sıtkı Koçman University, Muğla, Turkey.
  • Acıbadem Labmed Clinical Laboratories, İstanbul, Turkey.
  • Department of Medical Biochemistry, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, İstanbul, Turkey.
  • Department of Medical Biology, School of Medicine, Muğla Sıtkı Koçman University, Muğla, Turkey.

ORCID-Profile: Mervenur Yavuz, Betül Şahin, Ahmet Tarık Baykal, Turan Demircan

Zitieren

APA

Yavuz, M., Şahin, B., Baykal, A. T., & Demircan, T. (2023). Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating Apoptosis. Turkish Journal of Biology, 47(1), 44-60. https://doi.org/10.55730/1300-0152.2640

Vancouver

Yavuz M, Şahin B, Baykal AT, Demircan T. Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating Apoptosis. Turkish Journal of Biology. 2023;47(1):44-60. doi:10.55730/1300-0152.2640

BibTeX
@article{Yavuz2023,
  author = {Yavuz, Mervenur and Şahin, Betül and Baykal, Ahmet Tarık and Demircan, Turan},
  title = {Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating Apoptosis},
  journal = {Turkish Journal of Biology},
  year = {2023},
  volume = {47},
  number = {1},
  pages = {44--60},
  doi = {10.55730/1300-0152.2640}
}
Kostenlos starten →